Reaction to Nanotechnology Report That Calls for Stricter Nanotech Laws

Leading Nano Entrepreneur Can Provide Industry Perspective on

Woodrow Wilson Center Report

Jan 11, 2006, 00:00 ET from Altair Nanotechnologies Inc.

    RENO, Nev., Jan. 11 /PRNewswire/ -- The Woodrow Wilson International
 Center for Scholars today released a policy analysis of an industry that is
 projected to top $1-trillion within a decade -- nanotechnology.  The report
 outlines a "menu of possibilities" for government action to deal with the
 "adverse" effects of nanotechnology, and provides evidence that the author
 says is relevant to determining what needs to be done to manage the industry.
     As an independent creator and leading supplier of advanced ceramic
 nanomaterials, Altair Nanotechnologies CEO Alan Gotcher can share his thoughts
 on how this could include a facts based approach.
     WHO:    Alan J. Gotcher, Ph.D.
             President and chief executive officer of Altair Nanotechnologies
     WHY:    Regulation of nanoparticles needs to be fact driven.  In order to
             get the facts, we need to stimulate both increased federal
             investment in research and development to better understand the
             various families/classes of nanomaterials, and the development of
             strong corporate commitment to good nanotechnology stewardship.
             Altair Nanotechnologies is already on the road to strong corporate
             stewardship, with an ongoing partnership to study environmental
             and occupational safety with the National Institute for
             Occupational Safety and Health.
     HOW:    Contact Sanda Pecina  (202-367-1622, or
             Matt Taylor (202-367-1626) to schedule an interview or background
     Altairnano is a leading supplier and innovator of advanced ceramic
 nanomaterial technology. Based in Reno, Nevada, Altairnano has assembled a
 unique team of materials scientists who, coupled in collaborative ventures
 with industry partners and leading academic centers, have pioneered an array
 of intellectual property and products. Altairnano's robust proprietary
 technology platforms produce a variety of crystalline and non-crystalline
 nanomaterials of unique structure, performance, quality and cost. The company
 has scalable manufacturing capability to meet emerging nanomaterials demands.
 Altairnano's two divisions, Life Sciences and Performance Materials, are
 focused on applications where its nanotechnology may enable new high growth
 markets. The Life Sciences division is pursuing market applications in
 pharmaceuticals, drug delivery, dental materials and other medical markets.
 The Performance Materials division is focused on market applications in
 advanced materials for paints and coatings; air and water treatment and
 alternative energy, including new lithium ion battery electrode materials. For
 additional information on Altairnano and its nanomaterials, visit

SOURCE Altair Nanotechnologies Inc.